Sergi Sanchez-Cordero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sergi Sanchez-Cordero has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Julio Mayol
Hospital Clinico San Carlos, Instituto de Investigación Sanitaria San Carlos, Universidad Complutense, Madrid, Spain
3 shared publications- Ramon Vilallonga
Endocrine-Metabolic and Bariatric Surgery Unit, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
3 shared publications Inés Rubio Perez
Hospital Universitario La Paz, Madrid, Spain
2 shared publications- Jordi Pujol-Gebelli
Bariatric and Metabolic Surgery Unit, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain
2 shared publications Jose Luis Ramos Rodriguez
Hospital Universitario de Getafe, Getafe, Madrid, Spain
2 shared publicationsJosé M Balibrea del Castillo
Hospital Clinic de Barcelona, Barcelona, Spain
2 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (21) , 3622
Development of an Environmental Impact Calculator for Minimally Invasive Cholecystectomy: Protocol and Methodological Framework of the ECOMIS Project
One of the greatest threats to public health in the 21st century is anthropogenic climate change. Healthcare services worldwide account for 4.9% of global CO2 emissions, with operating rooms being the most resource-intensive areas of the hospital. The need for environmentally sustainable change is a priority. Reliable quantitative data on emissions remain limited, which may hinder informed decision-making on surgical sustainability. The aim of this study is to develop and validate an easily accessible and user-friendly calculator to quantitatively estimate procedure-related carbon dioxide equivalent (CO2-eq) emissions of minimally invasive cholecystectomy across a range of countries, hospital volumes, and healthcare settings. The ECOMIS project follows a multiphase, stepwise design. The present study will focus on minimally invasive cholecystectomies. The calculator variables will be selected based on a systematic literature review of factors influencing CO2-eq emissions, with life cycle assessment (LCA) considered an established and comprehensive methodology for assessing CO2-eq emissions. The project will generate a comprehensive quantitative overview of the environmental impact associated with key variables involved in minimally invasive surgery. This tool has the potential to facilitate tailor-made and evidence-based decision-making and promote more sustainable surgical practices.
- 26 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (21) , 3622
Open AccessDevelopment of an Environmental Impact Calculator for Minimally Invasive Cholecystectomy: Protocol and Methodological Framework of the ECOMIS Project
One of the greatest threats to public health in the 21st century is anthropogenic climate change. Healthcare services worldwide account for 4.9% of global CO2 emissions, with operating rooms being the most resource-intensive areas of the hospital. The need for environmentally sustainable change is a priority. Reliable quantitative data on emissions remain limited, which may hinder informed decision-making on surgical sustainability. The aim of this study is to develop and validate an easily accessible and user-friendly calculator to quantitatively estimate procedure-related carbon dioxide equivalent (CO2-eq) emissions of minimally invasive cholecystectomy across a range of countries, hospital volumes, and healthcare settings. The ECOMIS project follows a multiphase, stepwise design. The present study will focus on minimally invasive cholecystectomies. The calculator variables will be selected based on a systematic literature review of factors influencing CO2-eq emissions, with life cycle assessment (LCA) considered an established and comprehensive methodology for assessing CO2-eq emissions. The project will generate a comprehensive quantitative overview of the environmental impact associated with key variables involved in minimally invasive surgery. This tool has the potential to facilitate tailor-made and evidence-based decision-making and promote more sustainable surgical practices.
- Open Access
- 21 May 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (7) , 4002
Correction to: Short-term Safety of one Anastomosis Gastric Bypass (OAGB) Versus Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S): 30-day Results from the OASIS trial
- 21 May 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (7) , 4002
Open AccessCorrection to: Short-term Safety of one Anastomosis Gastric Bypass (OAGB) Versus Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S): 30-day Results from the OASIS trial
- 28 February 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (4) , 1583-1589
Short-term Safety of one Anastomosis Gastric Bypass (OAGB) Versus Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S): 30-day Results from the OASIS trial
- 28 February 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (4) , 1583-1589
Short-term Safety of one Anastomosis Gastric Bypass (OAGB) Versus Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S): 30-day Results from the OASIS trial
- 1 September 2024
- Published by SAGE Publications in Bariatric Surgical Practice and Patient Care
- Vol. 19 (3) , 107-113
Weight Loss Speed and Early Predictors to Success After Bariatric Surgery
Background: Despite marked weight loss after bariatric surgery (BS), there is a subset of patients who fails to achieve a successful weight loss or experiences long-term weight regain. Defining the early factors linked to BS unsuccess is mandatory to promote prompt intervention to optimize weight loss (WL). Controversial data are available about predictors of success. We aimed to retrospectively assess whether clinical baseline characteristics of patients submitted to BS, the speed of weight loss (WLspeed), or early predictors factors were associated with successful WL after 5 years of follow-up. Methods: This is a retrospective database study of a prospective cohort with a 5-year follow-up. We established the success or failure of bariatric surgery in terms of weight loss according to a selected criterion: (1) Brolin, (2) Reinhold modified by Christou, (3) Biron, (4) total weight loss (TWL) > 20%, and (5) percentage of changeable weight loss (%AWL) >35%. We analyze the WLspeed as the mean difference between body mass index (BMI) at 6 months or BMI at 12 months and the baseline BMI, and a multivariate analysis was performed. Results: In total, 223 (38.7%) patients underwent sleeve gastrectomy and 353 (61.2%) underwent laparoscopic Roux-en-Y gastric bypass (LRYGB). According to the criteria, the success rates at 5 years were: the excess weight loss (EWL) > 50% 464 (80%), Reinhold modified by Christou 436 (75.6%), Biron 530 (92%), TWL > 20% 493 (85.5%), and AWL < 35% 419 (72.7%). We found a strong correlation between the first year success and the long-term results for all the criteria included in the study. Among our patients, the better results in the long term are statistically significant younger 44 versus 47 years old ( p < 0.001) and lighter 45.4 versus 46.9 ( p < 0.05) with higher proportion of women ( p < 0.05), RYGB ( p < 0.001), and less comorbidities: hypertension, diabetes mellitus type 2, and dyslipidemia ( p < 0.05). In our series, there were a statistically significant differences in the nadirBMI 26.1 versus 31( p < 0.001) and BMI at 5 years 28.5 versus 37 ( p < 0.001). Patients who achieved or surpassed the mean WLspeed >13, 15, at 6 months or >16, 15 at 12 months were more likely to achieve success in any criteria proposed ( p < 0.001). Conclusion: In conclusion, our results demonstrate that the greater the initial weight loss after BS, the better the outcomes are. However, the speed to lose weight in the first year after surgery is not a success criterion in the long term. Patients with higher %EWL, %TWL, and %AWL at 6 months after BS might be at state of future success.
- 1 September 2024
- Published by SAGE Publications in Bariatric Surgical Practice and Patient Care
- Vol. 19 (3) , 107-113
Weight Loss Speed and Early Predictors to Success After Bariatric Surgery
Background: Despite marked weight loss after bariatric surgery (BS), there is a subset of patients who fails to achieve a successful weight loss or experiences long-term weight regain. Defining the early factors linked to BS unsuccess is mandatory to promote prompt intervention to optimize weight loss (WL). Controversial data are available about predictors of success. We aimed to retrospectively assess whether clinical baseline characteristics of patients submitted to BS, the speed of weight loss (WLspeed), or early predictors factors were associated with successful WL after 5 years of follow-up. Methods: This is a retrospective database study of a prospective cohort with a 5-year follow-up. We established the success or failure of bariatric surgery in terms of weight loss according to a selected criterion: (1) Brolin, (2) Reinhold modified by Christou, (3) Biron, (4) total weight loss (TWL) > 20%, and (5) percentage of changeable weight loss (%AWL) >35%. We analyze the WLspeed as the mean difference between body mass index (BMI) at 6 months or BMI at 12 months and the baseline BMI, and a multivariate analysis was performed. Results: In total, 223 (38.7%) patients underwent sleeve gastrectomy and 353 (61.2%) underwent laparoscopic Roux-en-Y gastric bypass (LRYGB). According to the criteria, the success rates at 5 years were: the excess weight loss (EWL) > 50% 464 (80%), Reinhold modified by Christou 436 (75.6%), Biron 530 (92%), TWL > 20% 493 (85.5%), and AWL < 35% 419 (72.7%). We found a strong correlation between the first year success and the long-term results for all the criteria included in the study. Among our patients, the better results in the long term are statistically significant younger 44 versus 47 years old ( p < 0.001) and lighter 45.4 versus 46.9 ( p < 0.05) with higher proportion of women ( p < 0.05), RYGB ( p < 0.001), and less comorbidities: hypertension, diabetes mellitus type 2, and dyslipidemia ( p < 0.05). In our series, there were a statistically significant differences in the nadirBMI 26.1 versus 31( p < 0.001) and BMI at 5 years 28.5 versus 37 ( p < 0.001). Patients who achieved or surpassed the mean WLspeed >13, 15, at 6 months or >16, 15 at 12 months were more likely to achieve success in any criteria proposed ( p < 0.001). Conclusion: In conclusion, our results demonstrate that the greater the initial weight loss after BS, the better the outcomes are. However, the speed to lose weight in the first year after surgery is not a success criterion in the long term. Patients with higher %EWL, %TWL, and %AWL at 6 months after BS might be at state of future success.
- 17 February 2024
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 103 (1) , 1-2
Evaluation of ChatGPT in surgical research
- 17 February 2024
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 103 (1) , 1-2
Evaluation of ChatGPT in surgical research
- Open Access
- 26 December 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (1) , 187
Analysis of the Variability in Different Criteria to Define the Success of Bariatric Surgery: Retrospective Study 5-Year Follow-Up after Sleeve Gastrectomy and Roux-en-Y Gastric Bypass
(1) Background: The current criteria for defining good or bad responders to bariatric surgery based on the percentage of weight loss do not properly reflect the therapeutic impact of the main bariatric techniques. At present there is an urgent need to fill this gap and provide scientific evidence that better define the success or failure of bariatric surgery in the long term. (2) Methods: This is a retrospective database study of a prospective cohort with 5-year follow-up. We established the success or failure of bariatric surgery in terms of weight loss according to a selected criterion: (1) Halverson and Koehler; (2) Reinhold modified by Christou; (3) Biron; (4) TWL > 20%; (5) percentage of changeable weight (AWL > 35%). We analyzed sensitivity and specificity for successful weight loss. (3) Results: 223 (38.7%) patients underwent sleeve gastrectomy (LSG) and 353 (61.2%) underwent laparoscopic Roux-en-Y gastric bypass (LRYGBP). The success rates at 5 years are: EWL > 50% 464 (80%), Reinhold 436 (75.6%), Biron 530 (92%), TWL > 20% 493 (85.5%), AWL < 35% 419 (72.7); ≥50% EWL and alterable weight loss AWL > 35 were the most adequate criteria as their specificities and sensibility were far above >80%. (4) Conclusions: The present study shows how the different definitions of success or failure are inconsistent in relation to the outcomes of BS. However, there are some criteria that associate statistically significant differences for the resolution of comorbidities and show the highest sensitivity and specificity rates.
- 26 December 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (1) , 187
Open AccessAnalysis of the Variability in Different Criteria to Define the Success of Bariatric Surgery: Retrospective Study 5-Year Follow-Up after Sleeve Gastrectomy and Roux-en-Y Gastric Bypass
(1) Background: The current criteria for defining good or bad responders to bariatric surgery based on the percentage of weight loss do not properly reflect the therapeutic impact of the main bariatric techniques. At present there is an urgent need to fill this gap and provide scientific evidence that better define the success or failure of bariatric surgery in the long term. (2) Methods: This is a retrospective database study of a prospective cohort with 5-year follow-up. We established the success or failure of bariatric surgery in terms of weight loss according to a selected criterion: (1) Halverson and Koehler; (2) Reinhold modified by Christou; (3) Biron; (4) TWL > 20%; (5) percentage of changeable weight (AWL > 35%). We analyzed sensitivity and specificity for successful weight loss. (3) Results: 223 (38.7%) patients underwent sleeve gastrectomy (LSG) and 353 (61.2%) underwent laparoscopic Roux-en-Y gastric bypass (LRYGBP). The success rates at 5 years are: EWL > 50% 464 (80%), Reinhold 436 (75.6%), Biron 530 (92%), TWL > 20% 493 (85.5%), AWL < 35% 419 (72.7); ≥50% EWL and alterable weight loss AWL > 35 were the most adequate criteria as their specificities and sensibility were far above >80%. (4) Conclusions: The present study shows how the different definitions of success or failure are inconsistent in relation to the outcomes of BS. However, there are some criteria that associate statistically significant differences for the resolution of comorbidities and show the highest sensitivity and specificity rates.
- 15 June 2022
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 100 (9) , 562-568
Trends of social networks in the American College of Surgeons Clinical Congress and the Congreso Nacional de Cirugía. Analysis of the #ACSCC20 and #CNCirugia2020
- 15 June 2022
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 100 (9) , 562-568
Trends of social networks in the American College of Surgeons Clinical Congress and the Congreso Nacional de Cirugía. Analysis of the #ACSCC20 and #CNCirugia2020
- Open Access
GERD after Bariatric Surgery. Can We Expect Endoscopic Findings?
Background and Objectives: Bariatric surgery remains the gold standard treatment for morbidly obese patients. Roux-en-y gastric bypass and laparoscopic sleeve gastrectomy are the most frequently performed surgeries worldwide. Obesity has also been related to gastroesophageal reflux disease (GERD). The management of a preoperative diagnosis of GERD, with/without hiatal hernia before bariatric surgery, is mandatory. Endoscopy can show abnormal findings that might influence the final type of surgery. The aim of this article is to discuss and review the evidence related to the endoscopic findings after bariatric surgery. Materials and Methods: A systematic review of the literature has been conducted, including all recent articles related to endoscopic findings after bariatric surgery. Our review of the literature has included 140 articles, of which, after final review, only eight were included. The polled articles included discussion of the endoscopy findings after roux-en-y gastric bypass and laparoscopic sleeve gastrectomy. Results: We found that the specific care of bariatric patients might include an endoscopic diagnosis when GERD symptoms are present. Conclusions: Recent evidence has shown that endoscopic follow-up after laparoscopic sleeve gastrectomy could be advisable, due to the pathological findings in endoscopic procedures in asymptomatic patients.
Open AccessGERD after Bariatric Surgery. Can We Expect Endoscopic Findings?
Background and Objectives: Bariatric surgery remains the gold standard treatment for morbidly obese patients. Roux-en-y gastric bypass and laparoscopic sleeve gastrectomy are the most frequently performed surgeries worldwide. Obesity has also been related to gastroesophageal reflux disease (GERD). The management of a preoperative diagnosis of GERD, with/without hiatal hernia before bariatric surgery, is mandatory. Endoscopy can show abnormal findings that might influence the final type of surgery. The aim of this article is to discuss and review the evidence related to the endoscopic findings after bariatric surgery. Materials and Methods: A systematic review of the literature has been conducted, including all recent articles related to endoscopic findings after bariatric surgery. Our review of the literature has included 140 articles, of which, after final review, only eight were included. The polled articles included discussion of the endoscopy findings after roux-en-y gastric bypass and laparoscopic sleeve gastrectomy. Results: We found that the specific care of bariatric patients might include an endoscopic diagnosis when GERD symptoms are present. Conclusions: Recent evidence has shown that endoscopic follow-up after laparoscopic sleeve gastrectomy could be advisable, due to the pathological findings in endoscopic procedures in asymptomatic patients.
- 1 June 2020
- Published by SAGE Publications in Bariatric Surgical Practice and Patient Care
- Vol. 15 (2) , 110-113
Management of Morbidly Obese Patients During the Outbreak of New Coronavirus Pandemic: Commentary and Recommendations from a Specialist Center in Spain
In December 2019, the outbreak of SARS-CoV-2 started in mainland China, rapidly spreading across the globe. Currently, there is a global pandemic situation, and, with more or less success, countries such as Italy, Spain, France, and United States have initiated a first-level response. In this framework, the management of morbidly obese patients has been greatly affected. This article reviews the current hotspot issues and discusses different management strategies for patients with morbid obesity during the pandemic. The aim of this communication is to provide advice to bariatric/metabolic surgeons worldwide regarding the management and treatment of morbidly obese patients during this COVID-19 pandemic.
- 1 June 2020
- Published by SAGE Publications in Bariatric Surgical Practice and Patient Care
- Vol. 15 (2) , 110-113
Management of Morbidly Obese Patients During the Outbreak of New Coronavirus Pandemic: Commentary and Recommendations from a Specialist Center in Spain
In December 2019, the outbreak of SARS-CoV-2 started in mainland China, rapidly spreading across the globe. Currently, there is a global pandemic situation, and, with more or less success, countries such as Italy, Spain, France, and United States have initiated a first-level response. In this framework, the management of morbidly obese patients has been greatly affected. This article reviews the current hotspot issues and discusses different management strategies for patients with morbid obesity during the pandemic. The aim of this communication is to provide advice to bariatric/metabolic surgeons worldwide regarding the management and treatment of morbidly obese patients during this COVID-19 pandemic.